We are live on ! Find out more
SM

Sabby Management Portfolio holdings

AUM $45.1M
1-Year Est. Return 74.25%
This Fund
S&P 500
This Quarter Est. Return
-34.3%
1 Year Est. Return
-74.25%
3 Year Est. Return
-95.86%
5 Year Est. Return
-99.36%
10 Year Est. Return
-99.46%
AUM
$115M
AUM Growth
+$792K
Cap. Flow
+$6.43M
Cap. Flow %
5.6%
Top 10 Hldgs %
83.12%
Holding
142
New
32
Increased
15
Reduced
32
Closed
53

Top Buys

Rank Stock Value
1
RCON icon
Recon Technology
RCON
+$5M
2
GMVD
G Medical Innovations Holdings Ltd. Ordinary Shares
GMVD
+$3.87M
3
BETS
Bit Brother Limited Class A Ordinary Shares
BETS
+$2.24M
4
CNEY icon
CN Energy Group
CNEY
+$2.19M
5
NMTR
9 Meters Biopharma
NMTR
+$2.08M

Top Sells

Rank Stock Value
1
NVCT icon
Nuvectis Pharma
NVCT
+$4.41M
2
TBLT
ToughBuilt Industries, Inc. Common Stock
TBLT
+$2.28M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$1.92M
4
BGXX
Bright Green Corporation Common Stock
BGXX
+$1.49M
5
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$1.34M

Sector Composition

Rank Sector Weight
1 Healthcare 9.81%
2 Technology 3.12%
3 Consumer Discretionary 2.1%
4 Communication Services 1.53%
5 Materials 1.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPY icon
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$783B
$48.1M 41.86%
1,173
+173
+17% +$69K
OEF icon
2
PUT
iShares S&P 100 ETF
OEF
$19.8B
$35.5M 30.95%
1,992
+199
+11% +$35.7K
BCTXW
3
PUT
DELISTED
BriaCell Therapeutics Corp Warrant
BCTXW
$2.4M 2.09%
3,228
-587
-15% -$1.69K
NMTR
4
DELISTED
9 Meters Biopharma
NMTR
$1.53M 1.34%
+1,103,645
New +$2.08M
AKTX
5
Akari Therapeutics
AKTX
$14.8M
$1.44M 1.26%
9,927
+5,342
+117% +$1.68M
TC
6
TuanChe
TC
$61M
$1.41M 1.23%
8,155
+57
+0.7% +$11.8K
DOGZ icon
7
Dogness International Corp
DOGZ
$14M
$1.37M 1.2%
92,582
-11,357
-11% -$214K
RCON icon
8
Recon Technology
RCON
$39.6M
$1.35M 1.18%
+219,315
New +$5M
GMVD
9
DELISTED
G Medical Innovations Holdings Ltd. Ordinary Shares
GMVD
$1.23M 1.07%
+1,350,000
New +$3.87M
TONX
10
TON Strategy Co
TONX
$185M
$1.09M 0.95%
+1,138
New +$1.48M
APCX
11
DELISTED
AppTech Payments
APCX
$1.03M 0.9%
+692,636
New +$1.68M
CNEY icon
12
CN Energy Group
CNEY
$4.85M
$850K 0.74%
+5,395
New +$2.19M
BNKK
13
Bonk Inc
BNKK
$8.32M
$846K 0.74%
+54,257
New +$1.09M
IBIO icon
14
PUT
iBio
IBIO
$69.1M
$726K 0.63%
+175
New +$4.5K
SCNI
15
Scinai Immunotherapeutics
SCNI
$1.36M
$704K 0.61%
32,597
+10,541
+48% +$260K
ARDS
16
DELISTED
Aridis Pharmaceuticals Inc. Common Stock
ARDS
$672K 0.59%
+2,140,174
New +$1.55M
PULM icon
17
Pulmatrix
PULM
$6.14M
$642K 0.56%
220,029
-81,914
-27% -$296K
BETS
18
DELISTED
Bit Brother Limited Class A Ordinary Shares
BETS
$633K 0.55%
+736
New +$2.24M
IFBD icon
19
Infobird
IFBD
$9.09M
$612K 0.53%
+1,365
New +$948K
SHFS icon
20
SHF Holdings
SHFS
$1.25M
$594K 0.52%
58,196
+50,168
+625% +$881K
VRPX
21
DELISTED
Virpax Pharmaceuticals, Inc. Common Stock
VRPX
$551K 0.48%
2,806
-1,147
-29% -$256K
HUDI icon
22
Huadi International Group
HUDI
$10.8M
$528K 0.46%
169,198
-122,411
-42% -$572K
BFRG icon
23
Bullfrog AI
BFRG
$10.8M
$511K 0.45%
+150,776
New +$512K
GLBS icon
24
Globus Maritime Ltd
GLBS
$60.9M
$482K 0.42%
430,746
-41,906
-9% -$48.1K
SONN
25
DELISTED
Sonnet BioTherapeutics
SONN
$438K 0.38%
+6,906
New +$1.12M
1
2 3 4 5

Similar funds

CG
Circumference Group Little Rock, Arkansas $44.6M AUM 5.21% 1-Year Est. Return
OC
Optimas Capital Central, Hong Kong $44.5M AUM 24.43% 1-Year Est. Return
ICCON
Investment Counsel Company of Nevada Las Vegas, Nevada $44.5M AUM 21.97% 1-Year Est. Return
PCM
Prentice Capital Management Greenwich, Connecticut $45.7M AUM 2.65% 1-Year Est. Return
CAS
CTC Alternative Strategies Chicago, Illinois $44M AUM 43.15% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return
MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
CTC
Corundum Trust Company Sioux Falls, South Dakota $43.8M AUM 20.07% 1-Year Est. Return

Sabby Management's Q1 2023 Portfolio in Review

As of Q1 2023, Sabby Management held 142 positions worth $115M, up 0.69% from $114M the previous quarter. Its ten largest holdings account for 83% of the portfolio.

Sabby Management deployed $6.43M of net new capital in Q1 2023, opening 32 new positions and adding to 15 existing holdings. Its largest new stake was Recon Technology: 219,315 shares worth $1.35M.

By sector, the portfolio is most concentrated in Healthcare at 9.8% of assets, down from 16% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Cocrystal Pharma, an estimated $792K trimmed.

  • Sabby Management's largest Q1 2023 buy was Recon Technology: 219,315 shares worth $1.35M.
  • Sabby Management added most to Akari Therapeutics in Q1 2023, an estimated $1.68M increase.
  • Sabby Management's biggest Q1 2023 reduction was Cocrystal Pharma, cutting an estimated $792K.
  • Sabby Management fully exited Nuvectis Pharma in Q1 2023, selling an estimated $4.41M.
  • Sabby Management's ten largest holdings make up 83% of its $115M portfolio in Q1 2023.
  • Sabby Management opened 32 new positions and closed 53 in Q1 2023.
  • Sabby Management's portfolio value rose 0.69% quarter-over-quarter to $115M.

Based on Sabby Management's 13F filing for Q1 2023, filed 15 May 2023.